Table 3.

PTX encapsulation efficiency of NT-IONPs and targeted IONPs

Nanoparticles	% of encapsulated PTX
NT-IONPs-PTX	85.59±0.22
LHRH-IONPs-PTX	82.57±0.26
AE105-IONPs-PTX	82.83±0.24
LHRH-AE105-IONPs-PTX	78.34±0.52

Abbreviations: PTX, paclitaxel; NT-IONPs, non-targeted IONPs; IONPs, iron oxide nanoparticles; NT-IONPs-PTX, PTX-loaded non-targeted IONPs; LHRH-IONPs-PTX, PTX-loaded luteinizing hormone-releasing hormone receptor peptide-targeted IONPs; AE105-IONPs-PTX, PTX-loaded urokinase-type plasminogen activator receptor peptide-targeted IONPs; LHRH-AE105-IONPs-PTX, PTX-loaded LHRH peptide- and AE105 peptide-targeted IONPs.